FOLFOX4 Plus Avastin: Worth a Try?

Researchers may have found new hope for patients with previously-treated advanced metastatic colorectal cancer. The treatment involves a chemotherapeutic regimen called FOLFOX4.

The study determined that patients treated with FOLFOX4 and Avastin tended to live approximately two months longer than those treated with a FOLFOX4 regimen alone.

In case you'd like to discuss this treatment option with your doctor, here's some information you may want to provide about the study. It was conducted by a research group at the University of Pennsylvania and the findings were presented at the 2005 American Society of Clinical Oncology GI meeting held in Hollywood, Florida.

Related Research:

• FOLFOX4 Drug Combo Proven Effective
  
• Adding Avastin May Add Years to Your Life

Related News:

• FDA Approval of Avastin as a Second-Line Treatment for Colon Cancer
  
• Avastin Approved in EU and Switzerland
  
• Avastin Warning
  
• FDA Approval of Avastin as a Colorectal Cancer Treatment

_{Source: Gale, Karla. Avastin, Eloxatin Plus Standard Therapy Prolong CRC Cancer Survival. Oncolink. 27 Jan. 2005. 24 Aug. 2006 [http://www.oncolink.com/resources/article.cfm?c=3&s=8&ss=23&id=11506&month=01&year=2005].}